Latest News in the pharma Industry

Market News

Catalent to acquire Pharmatek

Catalent to acquire Pharmatek

13 Sep 2016

Acquisition adds expanded drug development services and spray drying technology.

Read more 
Trend towards increased pharma exports and nutraceuticals reported at CPhI Korea

Trend towards increased pharma exports and nutraceuticals reported at CPhI Korea

13 Sep 2016

The Korean biosimilar market was another area that gathered much international interest at CPhI Korea.

Read more 
Horizon Discovery licenses biomanufacturing cell lines to CPI and NIBRT

Horizon Discovery licenses biomanufacturing cell lines to CPI and NIBRT

13 Sep 2016

This agreement allows any organisation, through CPI or NIBRT, to access Horizon’s biomanufacturing cell lines for research purposes.

Read more 
Lonza completes acquisition of InterHealth Nutraceuticals

Lonza completes acquisition of InterHealth Nutraceuticals

13 Sep 2016

The combination of the two businesses allows Lonza to offer InterHealth’s more than 15 branded ingredients, including its cornerstone ingredient, UC-II, which is revolutionizing the joint-health segment.

Read more 
Idifarma secures investment to boost international growth

Idifarma secures investment to boost international growth

12 Sep 2016

Suanfarma - a specialised supplier of raw materials to the pharmaceutical industry - acquires a stake in the CDMO.

Read more 
Thermo Fisher Scientific opens new clinical services Facility in South Korea

Thermo Fisher Scientific opens new clinical services Facility in South Korea

12 Sep 2016

Will provide cGMP storage, local labelling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to clinical site returns management.

Read more 
Santalis Pharmaceuticals issued patent for the use of sandalwood oil to treat cancers

Santalis Pharmaceuticals issued patent for the use of sandalwood oil to treat cancers

12 Sep 2016

Patent covers East Indian sandalwood oil-containing compositions that can be used to treat a variety of cancers.

Read more 
Saneca Pharma invests in small-scale API capabilities

Saneca Pharma invests in small-scale API capabilities

12 Sep 2016

The CDMO' investment will reinforce its expertise in opiate and synthetic drug development and production.

Read more 
Dechra receives FDA approval for first US generic entrant antibiotic

Dechra receives FDA approval for first US generic entrant antibiotic

11 Sep 2016

Is the first registration Dechra has achieved through Putney's development pipeline since it acquired the US-based business

Read more 
Alcami completes site investment and expansion in drug product manufacturing and development facilities

Alcami completes site investment and expansion in drug product manufacturing and development facilities

11 Sep 2016

Company has invested in semi-automated vacuum stopper equipment to generate prefilled syringe samples that can be used to screen and select components, complete compatibility studies, and conduct developmental stability studies.

Read more 
Vicks expands Sinex portfolio to offer targeted solutions to treat sinus symptoms

Vicks expands Sinex portfolio to offer targeted solutions to treat sinus symptoms

9 Sep 2016

“The Clear Your Head Medicine” is poised to lead the sinus category, offering clarity in a confusing allergy and cold aisle.

Read more 
Hikma invests in Chrono Therapeutics for the development of next generation transdermal drug delivery techbology

Hikma invests in Chrono Therapeutics for the development of next generation transdermal drug delivery techbology

8 Sep 2016

Chrono Therapeutics is developing a wearable transdermal drug delivery device offering a personalised behavioural support system that times nicotine delivery to when smokers have their strongest cravings.

Read more